Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,674.80
(
1.42%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
112.77
(
0.35%
)
Bitcoin
75,698.27
(
-0.10%
)
News Focus
News Focus

Replies to post #213326 on Biotech Values

Replies to #213326 on Biotech Values
icon url

DewDiligence

08/30/17 10:15 AM

#213346 RE: DewDiligence #213326

ADXS-NEO addendum: I’m surprised that melanoma—one of the most immunogenic cancers—is not one of the indications being tested in the phase-1 trial.
icon url

DewDiligence

09/07/17 9:46 AM

#213488 RE: DewDiligence #213326

(AMGN/ADXS)—Competition in neoantigen arena:

https://endpts.com/google-helps-boost-gritstones-neoantigen-rd-gamble-to-195m-as-researchers-prep-for-first-human-study